Cargando…

Bifunctional Peptidomimetic G Protein-Biased Mu-Opioid Receptor Agonist and Neuropeptide FF Receptor Antagonist KGFF09 Shows Efficacy in Visceral Pain without Rewarding Effects after Subcutaneous Administration in Mice

There is still an unmet clinical need to develop new pharmaceuticals for effective and safe pain management. Current pharmacotherapy offers unsatisfactory solutions due to serious side effects related to the chronic use of opioid drugs. Prescription opioids produce analgesia through activation of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dumitrascuta, Maria, Martin, Charlotte, Ballet, Steven, Spetea, Mariana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780937/ https://www.ncbi.nlm.nih.gov/pubmed/36557917 http://dx.doi.org/10.3390/molecules27248785

Ejemplares similares

Mechanistic Understanding of Peptide Analogues, DALDA, [Dmt(1)]DALDA, and KGOP01, Binding to the Mu Opioid Receptor
por: Dumitrascuta, Maria, et al.
Publicado: (2020)

Functional modulation of human delta opioid receptor by neuropeptide FF
por: Änkö, Minna-Liisa, et al.
Publicado: (2005)

Nonpeptide Small Molecule Agonist and Antagonist Original Leads for Neuropeptide FF1 and FF2 Receptors
por: Journigan, V. Blair, et al.
Publicado: (2014)

Antinociceptive Efficacy of the µ-Opioid/Nociceptin Peptide-Based Hybrid KGNOP1 in Inflammatory Pain without Rewarding Effects in Mice: An Experimental Assessment and Molecular Docking
por: Dumitrascuta, Maria, et al.
Publicado: (2021)

Diet-induced adaptive thermogenesis requires neuropeptide FF receptor-2 signalling
por: Zhang, Lei, et al.
Publicado: (2018)

Neuropeptide FF receptor 2 inhibits capsaicin-induced CGRP Upregulation in mouse trigeminal ganglion
por: Lin, Ya-Tin, et al.
Publicado: (2020)

Intracerebroventricular Neuropeptide FF Diminishes the Number of Apneas and Cardiovascular Effects Produced by Opioid Receptors’ Activation
por: Wojciechowski, Piotr, et al.
Publicado: (2020)

Role of neuropeptide FF in central cardiovascular and neuroendocrine regulation
por: Jhamandas, Jack H., et al.
Publicado: (2013)

The hypothalamic neuropeptide FF network is impaired in hypertensive patients
por: Goncharuk, Valeri D, et al.
Publicado: (2014)

Neuropeptide FF indirectly affects testicular morphogenesis and functions in medaka
por: Tomihara, Soma, et al.
Publicado: (2022)

Correction to: The knockdown of Neuropeptide FF receptor 2 inhibits capsaicin-induced CGRP Upregulation in mouse trigeminal ganglion
por: Lin, Ya-Tin, et al.
Publicado: (2020)

Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy
por: Olson, Keith M., et al.
Publicado: (2023)

Placement of Hydroxy Moiety on Pendant of Peptidomimetic Scaffold Modulates Mu and Kappa Opioid Receptor Efficacy
por: Harland, Aubrie A., et al.
Publicado: (2017)

Transcriptomic Changes in Mouse Bone Marrow-Derived Macrophages Exposed to Neuropeptide FF
por: Sun, Yulong, et al.
Publicado: (2021)

The mu opioid receptor and the orphan receptor GPR151 contribute to social reward in the habenula
por: Allain, Florence, et al.
Publicado: (2022)

Bifunctional peptide-based opioid agonist/nociceptin antagonist ligand for dual treatment of nociceptive and neuropathic pain
por: Lagard, Camille, et al.
Publicado: (2016)

Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in Smokers
por: Kuwabara, Hiroto, et al.
Publicado: (2014)

Opposite Effects of Neuropeptide FF on Central Antinociception Induced by Endomorphin-1 and Endomorphin-2 in Mice
por: Wang, Zi-long, et al.
Publicado: (2014)

Metabolism of Cryptic Peptides Derived from Neuropeptide FF Precursors: The Involvement of Insulin-Degrading Enzyme
por: Grasso, Giuseppe, et al.
Publicado: (2014)

Elevated Serum Neuropeptide FF Levels Are Associated with Cognitive Decline in Patients with Spinal Cord Injury
por: Sun, Shifei, et al.
Publicado: (2021)

Synthesis, Pharmacology, and Molecular Docking Studies on 6-Desoxo-N-methylmorphinans as Potent μ-Opioid Receptor Agonists
por: Dumitrascuta, Maria, et al.
Publicado: (2017)

The Role of Mu Opioid Receptors in High Fat Diet-Induced Reward and Potentiation of the Rewarding Effect of Oxycodone †
por: Iqbal, Asif, et al.
Publicado: (2023)

Comparison of physicochemical properties and biological activities of opioid morphinans interacting with mu opioid receptors
por: Asim, Muhammad F, et al.
Publicado: (2008)

Activation of the Mu-Delta Opioid Receptor Heteromers Blocks Morphine Rewarding Effects
por: Requana Aradas, Ariadna, et al.
Publicado: (2023)

In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist - neurokinin 1 receptor antagonist chimera
por: Guillemyn, Karel, et al.
Publicado: (2012)

Bifunctional Opioid/Melanocortin Peptidomimetics for Use in Neuropathic Pain: Variation in the Type and Length of the Linker Connecting the Two Pharmacophores
por: Witkowska, Ewa, et al.
Publicado: (2022)

Neuropeptide S- and Neuropeptide S receptor-expressing neuron populations in the human pons
por: Adori, Csaba, et al.
Publicado: (2015)

Identification of neuropeptides and neuropeptide receptor genes in Phauda flammans (Walker)
por: Wu, Hai-Pan, et al.
Publicado: (2022)

Molecular Evolution of the Neuropeptide S Receptor
por: Pitti, Thejkiran, et al.
Publicado: (2012)

Mu opioid receptors on vGluT2‐expressing glutamatergic neurons modulate opioid reward
por: Reeves, Kaitlin C., et al.
Publicado: (2020)

Mechanism of opioid addiction and its intervention therapy: Focusing on the reward circuitry and mu‐opioid receptor
por: Zhang, Jia‐Jia, et al.
Publicado: (2022)

Identification and characterization of plant-derived alkaloids, corydine and corydaline, as novel mu opioid receptor agonists
por: Kaserer, Teresa, et al.
Publicado: (2020)

G(s) protein peptidomimetics as allosteric modulators of the β(2)-adrenergic receptor
por: Boyhus, Lotte-Emilie, et al.
Publicado: (2018)

Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists
por: Vasile, Silvana, et al.
Publicado: (2020)

N-Phenethyl Substitution in 14-Methoxy-N-methylmorphinan-6-ones Turns Selective µ Opioid Receptor Ligands into Dual µ/δ Opioid Receptor Agonists
por: Dumitrascuta, Maria, et al.
Publicado: (2020)

Visceral and subcutaneous fat
por: Lederman, Henrique Manoel
Publicado: (2014)

S. A. ff. Dakin
Publicado: (1962)

Morphine-induced mu opioid receptor trafficking enhances reward yet prevents compulsive drug use
por: Berger, Amy Chang, et al.
Publicado: (2011)

The ATP Synthase Subunits FfATPh, FfATP5, and FfATPb Regulate the Development, Pathogenicity, and Fungicide Sensitivity of Fusarium fujikuroi
por: Yang, Xin, et al.
Publicado: (2023)

TouchScreen-based phenotyping: altered stimulus/reward association and lower perseveration to gain a reward in mu opioid receptor knockout mice
por: Boulos, Laura-Joy, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2ugra9vrnjgf07ed01c81r4avn